Document is current
Any future updates will be listed below
-
Authors
Panja, Sukanya
Mantri, Padmaja
Johnson, Kofi Ennu
Andrade-Martinez, Juan Sebastian https://orcid.org/0000-0001-7852-630X
Yang, Soo-Ryum
Deshpande, Aditya
Tian, Huasong
Beg, Shaham https://orcid.org/0000-0002-6068-1595
Ohara, Kentaro
Leal, Alessandro https://orcid.org/0000-0001-7967-3213
Rosiene, Joel https://orcid.org/0000-0002-8610-370X
Stoeckius, Marlon
Smibert, Peter https://orcid.org/0000-0003-0772-1647
Travis, William D.
Mosquera, Juan Miguel https://orcid.org/0000-0003-4666-6476
Polak, Paz
Imieliński, Marcin https://orcid.org/0000-0002-2211-4741
-
Funding
Funding for this research was provided by:
Pershing Square Foundation (PSSCRA Award)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R37CA229861, CA264032)
- License Information
-
More Information
Article History
Received: 18 March 2022
Accepted: 21 October 2025
First Online: 27 November 2025
Competing interests
: M.I. reports receiving personal or consultancy fees from ImmPACT Bio outside of the scope of the submitted work. M.S. and P.S. report receiving personal fees from 10× Genomics outside of the scope of the submitted work. P.P. reports receiving personal fees from C2I-Genomics outside of the scope of the submitted work. S.R.Y. reports receiving speaking fees from Medscape, Onclive, Medical Learning Institute, PRIME Education, AstraZeneca and Roche outside of the scope of the submitted work. S.R.Y. reports consultancy fees from AstraZeneca, AbbVie, Merus, Eli Lilly, Boehringer Ingelheim, Roche, Amgen and Sanofi outside of the scope of the submitted work. The remaining authors declare no competing interests.
